Cancer Gene Therapy
Findings from Qingdao University broaden understanding of cancer gene therapy
Published in Gene Therapy Weekly, May 14th, 2009
According to a study from Qingdao, People's Republic of China, "CD59, belonging to membrane complement regulatory proteins (mCRPs), inhibits the cytolytic activity of complement and is over-expressed in solid cancers, including ovary cancer. The aim of the present study was to construct recombinant retrovirus encoding shRNA targeted human CD59 and infect A2780 cells in order to investigate the relationship between decreased CD59 expression and tumorigenesis of ovary cancer. siCD59 and siCD59-C were successfully constructed and identified by PCR, restriction endonuclease analyses and DNA sequencing, respectively."
"The siCD59 was able to efficiently infect A2780 cells,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-05-14)
More Articles from Gene Therapy Weekly
- American Institute of Physics
Simulated gene therapy - Adenovirus
Reports from University of Western Ontario advance knowledge in adenovirus - Artificial Chromosomes
Study findings from Royal Children's Hospital provide new insights into artificial chromosomes - Breast Cancer
Research from A. Magnifico and colleagues provide new insights into breast cancer - Cutaneous T-Cell Lymphoma
Study findings from M.K. Kiessling et al broaden understanding of cutaneous t-cell lymphoma - Dengue Fever
Investigators at Colorado State University target dengue fever - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
